Ole Herman Ambur

Ole Herman Ambur is an Associate Professor at Oslo Metropolitan University (OsloMet) in the Faculty of Health Sciences, Department of Life Sciences and Health. His research focuses on Biomedical Laboratory Sciences, with particular expertise in Genetics and genomics and Medical microbiology. He is affiliated with the Genomics of microbial pathogens research group and maintains an active research profile with numerous publications spanning molecular biology, virology, and microbiology.

Dr. Ambur's research interests primarily center around microbial genomics and pathogen analysis. His work spans several key areas including HPV genomics and its relationship to cervical cancer, biofilm formation and antibiotic resistance in bacterial pathogens like Haemophilus influenzae, and viral transmission dynamics as demonstrated in his SARS-CoV-2 research. He has developed expertise in advanced genomic sequencing techniques including nanopore sequencing and computational modeling approaches for analyzing pathogen genomes. His research on HPV integration patterns, APOBEC3 editing profiles, and viral evolution has significant implications for understanding cervical cancer development.

His publication record shows a strong focus on applied genomics research with significant contributions to understanding HPV integration patterns, viral evolution, and bacterial biofilm resistance mechanisms. Recent work has increasingly incorporated advanced computational approaches including AlphaFold for protein-DNA interaction modeling. His development of methodologies like TaME-seq2 demonstrates innovation in viral genomic profiling techniques. The 2025 publications indicate ongoing cutting-edge research at the intersection of computational biology and experimental genomics.

Dr. Ambur has received research funding for projects related to microbial pathogen genomics, HPV research, and biofilm studies. His work on the CRCbiome study demonstrates collaboration on large-scale epidemiological research examining the gut microbiome's role in colorectal cancer. He has also contributed to professional development initiatives for Biomedical Laboratory Scientists with foreign credentials, showing commitment to educational aspects of his field.

He is actively involved with the Genomics of microbial pathogens research group and has contributed to developing sequencing methodologies like TaME-seq2 for viral genomic profiling. His work bridges computational biology, clinical microbiology, and molecular diagnostics, with applications in both viral and bacterial pathogen research. The collaborative nature of his publications indicates strong interdisciplinary connections across virology, oncology, and microbiology research domains.